The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price gain of 45.53% this year. Over the last six months, there has been a stronger performance of -26.19%. The price of TMDX fallen by 29.04% during the last 30 days period. For the last 5-days stocks have improved 2.83%.
The market performance of Transmedics Group Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $177.37 on 08/23/24, while the lowest value for the same duration was $55.00 on 01/21/25.
52-week price history of TMDX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Transmedics Group Inc’s current trading price is -48.84% away from its 52-week high, while its distance from the 52-week low is 64.98%. The stock’s price range during this period has varied between$55.00 and $177.37. The Transmedics Group Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.7 million for the day, a figure considerably lower than their average daily volume of 1.23 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Transmedics Group Inc (TMDX) has experienced a quarterly rise of 49.19% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.07B and boasts a workforce of 728 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 70.51, with a change in price of +3.43. Similarly, Transmedics Group Inc recorded 1,618,355 in trading volume during the last 100 days, posting a change of +3.94%.
TMDX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TMDX stands at 2.27. Similarly, the long-term debt-to-equity ratio is also 2.26.
TMDX Stock Stochastic Average
Transmedics Group Inc’s raw stochastic average for the past 50 days is presently 84.15%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 84.08%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 89.38% and 92.23%, respectively.
